Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
Douglas L SeidnerSimon M GabeHak-Myung LeeClément OlivierPalle Bekker JeppesenPublished in: JPEN. Journal of parenteral and enteral nutrition (2019)
Although this analysis was limited by low patient numbers, results suggest that SBS-IF characteristics of lower baseline PS volume and non-IBD etiology were associated with PS reduction benefits with teduglutide in terms of days off per week and enteral autonomy.